Access To Medicine Foundation

Often searched

Index ranking

Vacancies

10 year analysis

  • Healthcare inequity
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
    • How big is the problem?
    • How we drive change
    • Our story
    • Our impact
  • Become a catalyst
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
    • Investors
    • Companies
    • Government & policymakers
    • Events & engagements
  • Sectors and research
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
    • R&D-based pharma companies
    • Medical gas companies
    • Generic medicine manufacturers
    • Diagnostics companies
    • Vaccine manufacturers
    • Research hub
    • Company profiles & report cards
  • Cross-Sector Programmes
    • Antimicrobial resistance
    • Diabetes care
    • Antimicrobial resistance
    • Diabetes care
  • On the pulse of global health
    • Access insights
    • The Health Equity podcast
    • Access insights
    • The Health Equity podcast
  • News
  • Our team
  • Featured insights
  • Governance & financials
  • Vacancies
  • Media coverage
  • FAQ
  • Contact us

Moy Bracken to share insights on patient reach at the EFGCP Better Medicines for Children Conference

Moy Bracken, Research Unit Manager at the Access to Medicine Foundation, has been invited to speak at the EFGCP Better Medicines for Children Conference 2024. The meeting will provide a forum to discuss how access- to- medicine strategies in low- and middle-income countries (LMICs) can be leveraged to improve patient reach of paediatric medicines.

Date

23 October 2024

Location

Brussels, Belgium

The European Forum for Good Clinical Practice (EFGCP) will be hosting its annual Better Medicines for Children conference in Brussels in October 2024, where global leaders in the paediatric medicine development space will be in attendance. 

In addition to discussing issues in Europe, this year’s event will also focus on key access-to-medicine issues faced in LMICs and how strategies for improving access in these countries can be applied to the distribution of paediatric medicines.

Moy will serve as a panelist for the “Pathways to medicines in LMICs” session on the second day of the event. At the roundtable, she plans to share the findings from the Foundation’s new report, launched on 10 September 2024, which looks at pharmaceutical companies’ strategies for improving patient reach of essential medicines.

About the roundtable

The session will be moderated by Martina Penazzato, team lead for the World Health Organization’s Research for Health Department, Science Division and Rhian Thomas-Turner, Research & Development lead at Noah's Ark Children's Hospital for Wales.

Moy joins other experts on the panel, including: 

  • Emmanuella Amoako, Director of Clinical Affairs at Yemaachi Biotech 

  • Lenias Hwenda, CEO of the Medicines for Africa Foundation 

Divya Verma

Head of Communications

dverma@accesstomedicinefoundation.org

Get in touch

Resource Centre

Explore our research reports and publications
Research

The Methodology for the 2024 Access to Medicine Index

10 October 2023
Event

Foundation and WEF’s joint event on equitable access: Meeting Report

18 June 2024
Media

There are far too many avoidable deaths in childbirth

18 January 2024

Access to Medicine Foundation

Interested in our work?

Access to Medicine Foundation is funded by

Terms & conditions

Privacy & cookie policy

Disclaimer

Copyright 2004 - 2025 Access to Medicine Foundation - All Rights Reserved